Edition:
United States

People: Lydall Inc (LDL.N)

LDL.N on New York Stock Exchange

46.65USD
18 Aug 2017
Change (% chg)

$0.05 (+0.11%)
Prev Close
$46.60
Open
$46.60
Day's High
$46.90
Day's Low
$46.45
Volume
24,279
Avg. Vol
22,199
52-wk High
$64.85
52-wk Low
$44.14

Burdett, Kathleen 

Ms. Kathleen Burdett is Independent Director of Lydall, Inc. She has served as Vice President and Chief Financial Officer of Dexter Corporation (“Dexter”), a developer and manufacturer of nonwoven products primarily used in the food packaging, medical, and hygiene markets, specialty polymers primarily used in the aerospace and electronics markets and precise, reproducible biological, and biochemical products used for applications in the life sciences industry, from 1994 until Dexter’s merger with Invitrogen Corporation (“Invitrogen”), in 2000. From 2000 until her retirement in 2002, Ms. Burdett served as a consultant to Invitrogen. Prior to that, Ms. Burdett served as the Controller and Principal Accounting Officer of Dexter and as a member of the Board of Directors of Life Technologies, Inc., a majority owned subsidiary of Dexter, and as Chair of the Audit Committee and as a member of the Executive Committee and the Compensation Committee of Life Technologies, Inc.

Basic Compensation

Total Annual Compensation, USD 88,500
Restricted Stock Awards, USD 50,075
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 138,575

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dale Barnhart

2,606,010

Scott Deakin

1,202,340

Joseph Abbruzzi

809,995

Paul Marold

1,328,170

Chad McDaniel

789,448

James Laughlan

419,943
As Of  30 Dec 2016